A J Kuryba1, N A Scott2, J Hill3, J H van der Meulen1,4, K Walker1,4. 1. Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK. 2. Colorectal Surgical Department, Lancashire Teaching Hospitals NHS Foundation Trust, Royal Preston Hospital, Preston, UK. 3. Department of General Surgery, Central Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Manchester, UK. 4. Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Abstract
AIM: The rate of ileostomy reversal was estimated in patients undergoing an elective anterior resection for rectal cancer and factors associated with reversal were identified. METHOD: The records of 4879 rectal patients who had an ileostomy created during anterior resection between 2009 and 2012 were identified in the National Bowel Cancer Audit database and linked to administrative records of the Hospital Episode Statistics. Patients were followed from surgery. Multivariable proportional hazards regression was used to estimate the impact of patient and cancer characteristics on ileostomy reversal with death as the competing risk. RESULTS: Within 18 months from anterior resection, 3536 (72.5%) patients had undergone ileostomy reversal. The reversal rate was lower in the following circumstances: older patients [hazard ratio (HR) 0.90; 95% CI 0.84-0.96, aged 80 vs 70 years], male gender (HR 0.90; 0.84-0.97), higher American Society of Anesthesiologists (ASA) grade (HR 0.64; 0.56-0.74, ASA 3+ vs 1), more advanced cancer (HR 0.77; 0.69-0.87, T3 vs T1), socioeconomic deprivation (HR 0.83; 0.74-0.93, most vs least deprived quintile), comorbidity (HR 0.92; 0.84-1.00, one vs no comorbidity) and open surgical procedure (HR 0.90; 0.84-0.97, open vs laparoscopic). CONCLUSION: Overall, two-thirds of ileostomies were reversed within 18 months. Reversal rates were linked to patient and cancer characteristics (age, sex, fitness and stage), mode of surgical access and socioeconomic deprivation. Observed lower reversal rates in patients from poorer backgrounds may indicate inequity in access. Colorectal Disease
AIM: The rate of ileostomy reversal was estimated in patients undergoing an elective anterior resection for rectal cancer and factors associated with reversal were identified. METHOD: The records of 4879 rectal patients who had an ileostomy created during anterior resection between 2009 and 2012 were identified in the National Bowel Cancer Audit database and linked to administrative records of the Hospital Episode Statistics. Patients were followed from surgery. Multivariable proportional hazards regression was used to estimate the impact of patient and cancer characteristics on ileostomy reversal with death as the competing risk. RESULTS: Within 18 months from anterior resection, 3536 (72.5%) patients had undergone ileostomy reversal. The reversal rate was lower in the following circumstances: older patients [hazard ratio (HR) 0.90; 95% CI 0.84-0.96, aged 80 vs 70 years], male gender (HR 0.90; 0.84-0.97), higher American Society of Anesthesiologists (ASA) grade (HR 0.64; 0.56-0.74, ASA 3+ vs 1), more advanced cancer (HR 0.77; 0.69-0.87, T3 vs T1), socioeconomic deprivation (HR 0.83; 0.74-0.93, most vs least deprived quintile), comorbidity (HR 0.92; 0.84-1.00, one vs no comorbidity) and open surgical procedure (HR 0.90; 0.84-0.97, open vs laparoscopic). CONCLUSION: Overall, two-thirds of ileostomies were reversed within 18 months. Reversal rates were linked to patient and cancer characteristics (age, sex, fitness and stage), mode of surgical access and socioeconomic deprivation. Observed lower reversal rates in patients from poorer backgrounds may indicate inequity in access. Colorectal Disease
Authors: Vera E M Grupa; Hidde M Kroon; Izel Ozmen; Sergei Bedrikovetski; Nagendra N Dudi-Venkata; Ronald A Hunter; Tarik Sammour Journal: Colorectal Dis Date: 2021-03-18 Impact factor: 3.788
Authors: Riccardo Lemini; Iktej S Jabbal; Krystof Stanek; Shalmali R Borkar; Aaron C Spaulding; Scott R Kelley; Dorin T Colibaseanu Journal: BMC Surg Date: 2021-03-25 Impact factor: 2.102
Authors: Greg A Turner; Kari A Clifford; Rossi Holloway; John C Woodfield; Mark Thompson-Fawcett Journal: Colorectal Dis Date: 2022-02-28 Impact factor: 3.917
Authors: Jelle P A Algie; Robert T van Kooten; Rob A E M Tollenaar; Michel W J M Wouters; Koen C M J Peeters; Jan Willem T Dekker Journal: Int J Colorectal Dis Date: 2022-09-26 Impact factor: 2.796
Authors: Rebecca J Birch; John C Taylor; Amy Downing; Katie Spencer; Paul J Finan; Riccardo A Audisio; Christopher M Carrigan; Peter J Selby; Eva J A Morris Journal: Eur J Surg Oncol Date: 2019-01-07 Impact factor: 4.424